Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bifunctional shRNA shows efficacy for the treatment of Ewing's sarcoma

May 26, 2014

Novel non-retinoid therapeutic for AMD significantly reduces RBP4 plasma levels

May 26, 2014

Novel uPAR-derived peptide tested for ocular angiogenesis-related diseases

May 26, 2014

Extended recombinant PTH treatment demonstrates good efficacy for hypoparathyroidism

May 26, 2014

Gilead's GS-5806 effective in phase IIa RSV trial

May 26, 2014

Pfizer researchers design nicotine vaccines with higher avidity

May 26, 2014

Empagliflozin evaluated in patients with diabetes and hypertension in phase III trials

May 23, 2014

IBI-302 investigated for AMD in vitro and in vivo

May 23, 2014

Novel azithromycin derivative identified for pulmonary inflammation

May 23, 2014

Interferon alpha inhibitor shows promise for the treatment of HIV encephalitis

May 23, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...